Molecular mechanisms in the pathogenesis of traumatic brain injury.

Department of Neurology, Clinical Science Building, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 309, Charleston, SC 29425, USA.
Histology and histopathology (Impact Factor: 2.24). 11/2002; 17(4):1137-52.
Source: PubMed

ABSTRACT Traumatic brain injury (TBI) is a serious neurodisorder commonly caused by car accidents, sports related events or violence. Preventive measures are highly recommended to reduce the risk and number of TBI cases. The primary injury to the brain initiates a secondary injury process that spreads via multiple molecular mechanisms in the pathogenesis of TBI. The events leading to both neurodegeneration and functional recovery after TBI are generalized into four categories: (i) primary injury that disrupts brain tissues; (ii) secondary injury that causes pathophysiology in the brain; (iii) inflammatory response that adds to neurodegeneration; and (iv) repair-regeneration that may contribute to neuronal repair and regeneration to some extent following TBI. Destructive multiple mediators of the secondary injury process ultimately dominate over a few intrinsic protective measures, leading to activation of cysteine proteases such as calpain and caspase-3 that cleave key cellular substrates and cause cell death. Experimental studies in rodent models of TBI suggest that treatment with calpain inhibitors (e.g., AK295, SJA6017) and neurotrophic factors (e.g., NGF, BDNF) can prevent neuronal death and dysfunction in TBI. Currently, there is still no precise therapeutic strategy for the prevention of pathogenesis and neurodegeneration following TBI in humans. The search continues to explore new therapeutic targets and development of promising drugs for the treatment of TBI.

  • [Show abstract] [Hide abstract]
    ABSTRACT: RBM5 (RNA-binding motif protein 5), a nuclear RNA binding protein, is known to trigger apoptosis and induce cell cycle arrest by regulating the activity of the tumor suppressor protein p53. However, its expression and function in spinal cord injury (SCI) are still unknown. To investigate whether RBM5 is involved in central nervous system injury and repair, we performed an acute SCI model in adult rats in this study. Our results showed RBM5 was unregulated significantly after SCI, which was accompanied with an increase in the levels of apoptotic proteins such as p53, Bax, and active caspase-3. Immunofluorescent labeling also showed that traumatic SCI induced RBM5 location changes and co-localization with active caspase-3 in neurons. To further probe the role of RBM5, a neuronal cell line PC12 was employed to establish an apoptotic model. Knockdown of RBM5 apparently decreased the level of p53 as well as active caspase-3, demonstrating its pro-apoptotic role in neurons by regulating expressions of p53 and caspase-3. Taken together, our findings indicate that RBM5 promotes neuronal apoptosis through modulating p53 signaling pathway following SCI.
    The International Journal of Biochemistry & Cell Biology 01/2015; 60. DOI:10.1016/j.biocel.2014.12.020 · 4.24 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Outcome after a traumatic brain injury (TBI) can be quite variable and unpredictable. This suggests factors other than injury severity play important roles in outcome. Host genotype might be one such factor. This chapter reviews key concepts important to understanding genetic influences on the response to and recovery from TBI. As an organizing framework, four broad contexts in which individual differences could play an important role in outcome after trauma are presented: (1) genes that may modulate injury extent and serve to augment or dampen the impact of a given "dose" of neurotrauma, (2) genes that may play a role in repair and recovery from injury and thus impact the trajectory of recovery and ultimate functional outcome, (3) genes modulating preinjury traits (e.g., resilience), or cognition (cognitive reserve), (4) interactions between genetic vulnerabilities to neurobehavioral disorders and neurotrauma (i.e., role of comorbidities). Each of these four broad categories involve multiple components and thus are under complex polygenic control suggesting that functional outcome following TBI is best viewed as a complex polygenic phenotype. Although the individual contribution of a given allele might be small, the effects of multiple alleles could be quite significant. © 2015 Elsevier B.V. All rights reserved.
    Handbook of Clinical Neurology 01/2015; 128:723-39. DOI:10.1016/B978-0-444-63521-1.00045-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: Traumatic brain injury (TBI) is a major cause of death and disability, and therefore an important health and socioeconomic problem for our society. Individuals surviving from a moderate to severe TBI frequently suffer from long-lasting cognitive deficits. Such deficits include different aspects of cognition such as memory, attention, executive functions, and awareness of their deficits. This chapter presents a review of the main neuropsychological and neuroimaging studies of patients with TBI. These studies found that patients evolve differently according to the severity of the injury, the mechanism causing the injury, and the lesion location. Further research is necessary to develop rehabilitation methods that enhance brain plasticity and recovery after TBI. In this chapter, we summarize current knowledge and controversies, focusing on cognitive sequelae after TBI. Recommendations from the Common Data Elements are provided, with an emphasis on diagnosis, outcome measures, and studies organization to make data more comparable across studies. Final considerations on neuroimaging advances, rehabilitation approaches, and genetics are described in the final section of the chapter. © 2015 Elsevier B.V. All rights reserved.
    Handbook of Clinical Neurology, Traumatic Brain Injury, Part II edited by Jordan Grafman, Andres M. Salazar, 02/2015: chapter 37: pages 579–611; Elsevier., ISBN: 978-0-444-63521-1

Full-text (2 Sources)

Available from
May 29, 2014